A susceptibility result can shift before the organism changes. That is why BRILLIANT Green Bile Broth 2% Culture Media must be considered together with inoculum, atmosphere, incubation, and endpoint reading. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 620010 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.

Analytical scope and method role

Brilliant Green Bile Broth 2% is a liquid medium used for the detection or confirmation of coliform bacteria in water and wastewater, foods, dairy products and other materials of sanitary importance. Brilliant Green Bile Broth 2% is formulated according to APHA, ISO 4831 and ISO 4832.

Method principle

Enzymatic digest of casein provides amino acids, nitrogen, carbon, vitamins and minerals for organisms growth. Lactose is the fermentable carbohydrate. Ox bile and brilliant green inhibit Gram-positive bacteria and many Gram-negative bacteria, other than coliforms.

Formula and functional interpretation

(g/l) Enzymatic Digest of Casein 10.0 Lactose 10.0 Ox Bile 20.0 Brilliant Green 0.0133 Final pH 7.2 ± 0.2 at 25°C

Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.

Preparation and execution: controlled method points

Preparation: Dehydrated medium Suspend 40.0* g of the powder in 1 liter of distilled or deionized water. Mix well. Heat to boil shaking frequently until completely dissolved. Distribute into 10 ml tubes with Durham gas collecting tube. Sterilize in autoclave at 121°C for 15 minutes. *Dissolve 80.0 g of the power in 1 liter of distilled or deionized water to make the double strength broth. Medium in bottles Aseptically, dispense the medium into tubes fitted with Durham tubes.

Procedure: 1.For coliforms detection, inoculate tubes with 1 ml diluted or undiluted sample (use double strength broth for larger volume samples). For use in the confirmation of presumptive tests, subculture from Lauryl Sulphate Tryptose Broth (ref. 21453) or from typical coliform colonies on Violet Red Bile Lactose Agar (ref. 11183). 2.To indicate the presence of Escherichia coli, incubate at 44 ± 1°C for 48 hours. ISO 4831 and ISO 4832 recommend to incubate at 30°C or 37°C for 24-48 hours. 3.Examine tubes for gas formation.

Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.

Quality control: what the control result protects

The tubes are inoculated with the microbial strains indicated in the QC table. Inoculum for productivity: ≤100 CFU. Inoculum for selectivity: >103 CFU. Incubation conditions: 30 ± 1°C for 24-48 hours. QC Table. Microorganism Growth Gas Escherichia coli WDCM 00012 Good + Escherichia coli WDCM 00013 Good + Citrobacter freundii WDCM 00006 Good + Enterococcus faecalis WDCM 00009 Partially to completely inhibited − Enterococcus faecalis WDCM 00087 Partially to completely inhibited − WARNING AND

Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.

Interpretation and confirmation pathway

Turbidity and gas production indicate coli-aerogenes organisms.

Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.

Storage, stability, and pre-use inspection

The powder is very hygroscopic, store the powder at 10-30°C, in a dry environment, in its original container tightly closed. Store bottles and tubes at 10-25°C away from light. Do not use the product beyond its expiry date on the label or if product shows any evidence of contamination or any sign of deterioration.

Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.

Limitations and boundaries of use

The product does not contain hazardous substances in concentrations exceeding the limits set by current legislation and therefore is not classified as dangerous. It is nevertheless recommended to consult the safety data sheet for its correct use. The product is intended for professional use only and must be used by properly trained operators.

Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.

Troubleshooting from evidence, not guesswork

  • Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
  • Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
  • Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
  • Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.

External method context

The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.

External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.

EUCAST disk diffusion and quality control

EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.

FDA Bacteriological Analytical Manual

FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.

WHO Laboratory Quality Management System handbook

WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.

Technical references

  1. Manufacturer product documentation for catalogue 620010.
  2. EUCAST disk diffusion and quality control (access checked 2026-07-20).
  3. FDA Bacteriological Analytical Manual (access checked 2026-07-20).
  4. WHO Laboratory Quality Management System handbook (access checked 2026-07-20).

Bench-use checklist

  • Verify product identity, catalogue number, lot, expiry, and storage history.
  • Document preparation and incubation exactly as controlled in the SOP.
  • Define controls and acceptance criteria before testing.
  • Record raw observations, control response, reading time, and confirmation decision.
  • Escalate failed controls, atypical reactions, and departures through the quality system.